Paul G Tarlano Dds Inc in Beaver Creek, OH - Dentist

Paul G Tarlano Dds Inc is a dental clinic (Dentist - General Practice) in Beaver Creek, Ohio. The current practice location for Paul G Tarlano Dds Inc is 3621 Dayton-xenia Rd, Beaver Creek, Ohio. For appointments, you can reach them via phone at (937) 426-9351. The mailing address for Paul G Tarlano Dds Inc is 3621 Dayton-xenia Rd, Beaver Creek, Ohio and phone number is (937) 426-9351.

Paul G Tarlano Dds Inc is licensed to practice in * (Not Available) (license number ) and its NPI number is 1194997718. This medical practice does not participate in medicare program and thus may not accept your medicare insurance. You may check if they accept your insurance at (937) 426-9351.

Contact Information

	Paul G Tarlano Dds Inc
	3621 Dayton-xenia Rd Beaver Creek OH 45432
	(937) 426-9351
	Not Available

Dental Care Clinic Profile

Full Name	Paul G Tarlano Dds Inc
Speciality	Dentist - General Practice
Location	3621 Dayton-xenia Rd, Beaver Creek, Ohio
Authorized Official Name and Position	Paul Gerald Tarlano (PRESIDENT)
Authorized Official Contact	9374269351
Accepts Medicare Insurance	This clinic does not participate in Medicare Program.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Paul G Tarlano Dds Inc 3621 Dayton-xenia Rd Beaver Creek OH 45432 Ph: (937) 426-9351	Paul G Tarlano Dds Inc 3621 Dayton-xenia Rd Beaver Creek OH 45432 Ph: (937) 426-9351

NPI Details:

NPI Number	1194997718
Provider Enumeration Date	03/25/2008
Last Update Date	03/25/2008

Medical Identifiers

Medical identifiers for Paul G Tarlano Dds Inc such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1194997718	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
1223G0001X	Dentist - General Practice	(* (Not Available))	Primary

News Archive

Janssen, Bayer HealthCare announce results from landmark studies evaluating safety profile of XARELTO in NVAF patients

Janssen Pharmaceuticals, Inc., and its development partner, Bayer HealthCare, today announced results from PMSS (Post-Marketing Safety Surveillance) and XANTUS (XARELTO for Prevention of Stroke in Patients with Atrial Fibrillation), their landmark real-world studies evaluating the safety of XARELTO in people with non-valvular atrial fibrillation (NVAF).

Mobile apps improve atrial fibrillation detection rates in a low-risk population

A new study has shown that mobile health (mHealth) devices are able to screen for the common cardiac disorder called atrial fibrillation (AF).

HCA posts cost of services for uninsured online

Tennessee-based hospital chain HCA on Friday began posting the prices of services for the uninsured at its hospitals in San Antonio and Austin, Texas, according to spokesperson Ed Fishbough, the Tennessean reports.

Study documents intrauterine transmission of SARS-CoV-2 infection during pregnancy

A baby girl in Texas - born prematurely to a mother with COVID-19 - is the strongest evidence to date that intrauterine (in the womb) transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) can occur, reports The Pediatric Infectious Disease Journal, the official journal of The European Society for Paediatric Infectious Diseases.

Paul G Tarlano Dds Inc - Dental Clinic in Beaver Creek, OH